Clinical Trial: Axicabtagene Ciloleucel Expanded Access Study

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access:   Available for Treatment IND/Protocol




Official Title: Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Relapsed/Refractory Transplant-Ineligible Aggressive Non-Hodgkin Lymphoma (N

Brief Summary: This is a multicenter, open-label expanded access protocol for the treatment of subjects with relapsed/refractory transplant ineligible aggressive NHL.